Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-24 4:31 pm Sale |
2023-02-23 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 83,880,935 37.800% |
-664,772 (-0.79%) |
Filing History |
| 2023-02-10 4:01 pm Purchase |
2022-12-31 | 13G | Immatics N.V. IMTX |
dievini Hopp BioTech holding GmbH & Co KG | 17,202,356 26.200% |
1 (+0.00%) |
Filing History |
| 2023-02-10 4:01 pm Sale |
2022-12-31 | 13G | AC Immune SA ACIU |
dievini Hopp BioTech holding GmbH & Co KG | 16,316,742 19.500% |
-1,724,258 (-9.56%) |
Filing History |
| 2022-11-14 4:02 pm Sale |
2022-11-08 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 84,545,707 45.200% |
-1,614,683 (-1.87%) |
Filing History |
| 2022-05-05 4:01 pm Sale |
2022-05-04 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,160,390 46.000% |
-158,700 (-0.18%) |
Filing History |
| 2022-03-17 5:10 pm Purchase |
2022-03-17 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,319,090 46.200% |
396,349 (+0.46%) |
Filing History |
| 2022-02-22 06:26 am Sale |
2022-02-22 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 85,922,741 46.000% |
-158,700 (-0.18%) |
Filing History |
| 2022-02-11 4:00 pm Purchase |
2021-12-31 | 13G | Immatics N.V. IMTX |
dievini Hopp BioTech holding GmbH & Co KG | 17,202,355 27.300% |
726,282 (+4.41%) |
Filing History |
| 2022-01-13 4:14 pm Purchase |
2022-01-13 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,081,441 46.000% |
11,667 (+0.01%) |
Filing History |
| 2021-10-15 1:21 pm Sale |
2021-10-11 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,069,774 46.100% |
-1,449,193 (-1.66%) |
Filing History |
| 2021-02-12 1:02 pm Purchase |
2020-12-31 | 13G | Immatics N.V. IMTX |
dievini Hopp BioTech holding GmbH & Co KG | 16,476,073 26.200% |
16,476,073 (New Position) |
Filing History |
| 2021-02-12 10:59 am Sale |
2020-12-31 | 13G | AC Immune SA ACIU |
dievini Hopp BioTech holding GmbH & Co KG | 18,041,000 25.100% |
-174,750 (-0.96%) |
Filing History |
| 2020-08-24 10:44 am Purchase |
2020-10-14 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 87,518,967 49.200% |
87,518,967 (New Position) |
Filing History |